Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2020

Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2020



This Medical Devices sector report, Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Deep Brain Stimulators (DBS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically-implanted electrodes to specific targets in the brain. DBSs are commonly used to treat movement disorders as well as neuropsychiatric disorders.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Deep Brain Stimulators (DBS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

2 Introduction
2.1 Deep Brain Stimulators (DBS) Overview
3 Products under Development
3.1 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
3.2 Deep Brain Stimulators (DBS) - Pipeline Products by Territory
3.3 Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
3.4 Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
3.5 Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
4 Deep Brain Stimulators (DBS) - Pipeline Products under Development by Companies
4.1 Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
4.2 Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
5 Deep Brain Stimulators (DBS) Companies and Product Overview
5.1 Adaptive Neuromodulation GmbH Company Overview
5.2 Adept Neuro SA Company Overview
5.3 Aleva Neurotherapeutics SA Company Overview
5.4 Baylor College of Medicine Company Overview
5.5 Bioinduction Limited Company Overview
5.6 Boston Scientific Corp Company Overview
5.7 Brainsway Ltd Company Overview
5.8 Cleveland Medical Devices Inc Company Overview
5.9 Clinatec Company Overview
5.10 Deep Brain Innovations, LLC Company Overview
5.11 Enspire DBS Therapy Inc Company Overview
5.12 Functional Neuromodulation Inc. Company Overview
5.13 Louisiana State University Company Overview
5.14 Massachusetts General Hospital Company Overview
5.15 Massachusetts Institute of Technology Company Overview
5.16 Medtronic Plc Company Overview
5.17 National Cheng-Kung University Hospital Company Overview
5.18 NeuroOne Inc Company Overview
5.19 Neuroparticle Corp Company Overview
5.20 NeuroPro Technologies Inc Company Overview
5.21 Neurosigma Inc Company Overview
5.22 Newronika s.r.l. Company Overview
5.23 Nexeon MedSystems Inc Company Overview
5.24 Nia Therapeutics Inc Company Overview
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.26 St. Jude Medical LLC Company Overview
5.27 Sunnybrook Health Sciences Centre Company Overview
5.28 SUNY Downstate Medical Center Company Overview
5.29 University of California Los Angeles Company Overview
5.30 University of Central Florida Company Overview
5.31 University of Florida Company Overview
5.32 University of Houston Company Overview
5.33 University of Illinois Company Overview
5.34 University of Milan Company Overview
5.35 University of Oxford Company Overview
5.36 University of Rochester Company Overview
5.37 University of South Florida Company Overview
5.38 Wedge Therapeutics Company Overview
6 Deep Brain Stimulators (DBS)- Recent Developments
6.1 Sep 10, 2020: TMS Clinics of Canada opens new facility to offer deep Transcranial Magnetic Stimulation (Deep TMS) for patients With Major Depressive Disorder (MDD)
6.2 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
6.3 Feb 26, 2020: Mayo Clinic reports remarkable growth in 2019
6.4 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.5 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.6 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.7 Feb 10, 2020: BrainsWay appoints Avner Lushi to Join Board of Directors
6.8 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
6.9 Jan 27, 2020: Abbott secures expanded FDA approval for Infinity DBS System
6.10 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
6.11 Jan 09, 2020: Medtronic receives CE Mark approval for the Percept PC Neurostimulator DBS System with BrainSense Technology
6.12 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health
6.13 Dec 17, 2019: Aleva Neurotherapeutics gets CE Mark for brain stimulation system
6.14 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.15 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform
6.16 Dec 02, 2019: BrainsWay announces successful results in pivotal multicenter study evaluating deep Transcranial Magnetic Stimulation System as an aid in smoking cessation
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List Of Tables

Table 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Table 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Table 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Table 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Table 6: Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Table 7: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CR-Capable Implant - Product Status
Table 10: CR-Capable Implant - Product Description
Table 11: Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Stereo-Electro-Encephalo-Graphie Electrode - Product Status
Table 13: Stereo-Electro-Encephalo-Graphie Electrode - Product Description
Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: directSTIM - Product Status
Table 16: directSTIM - Product Description
Table 17: Aleva Neurotherapeutics SA - Ongoing Clinical Trials Overview
Table 18: directSTIM - A Prospective, Multi-center, Post-market Clinical Follow-up Study of the directSTIM Deep Brain Stimulation (DBS) System
Table 19: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Adaptive Deep Brain Stimulation (aDBS) Device - Product Status
Table 21: Adaptive Deep Brain Stimulation (aDBS) Device - Product Description
Table 22: Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Picostim - Product Status
Table 24: Picostim - Product Description
Table 25: Bioinduction Limited - Ongoing Clinical Trials Overview
Table 26: Picostim - Simpler and Safer Deep Brain Stimulation for Parkinsons Disease
Table 27: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
Table 29: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
Table 30: Next Generation DBS System - Product Status
Table 31: Next Generation DBS System - Product Description
Table 32: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Deep TMS System - Alzheimers Disease - Product Status
Table 34: Deep TMS System - Alzheimers Disease - Product Description
Table 35: Deep TMS System - Bipolar Disorder - Product Status
Table 36: Deep TMS System - Bipolar Disorder - Product Description
Table 37: Deep TMS System - Multiple Sclerosis - Product Status
Table 38: Deep TMS System - Multiple Sclerosis - Product Description
Table 39: Deep TMS System - Post-Stroke - Product Status
Table 40: Deep TMS System - Post-Stroke - Product Description
Table 41: Deep TMS System - PTSD - Product Status
Table 42: Deep TMS System - PTSD - Product Description
Table 43: Deep TMS System - Smoking Cessation - Product Status
Table 44: Deep TMS System - Smoking Cessation - Product Description
Table 45: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Status
Table 46: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Description
Table 47: Next-Generation Multi-Channel TMS Stimulator - Product Status
Table 48: Next-Generation Multi-Channel TMS Stimulator - Product Description
Table 49: Brainsway Ltd - Ongoing Clinical Trials Overview
Table 50: Deep TMS System - Bipolar Disorder - A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression

List Of Figures

Figure 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Figure 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Figure 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Figure 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Figure 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available